Superior vena cava syndrome surgery: Difference between revisions
(Mahshid) |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Elective stent placement and surgical bypass is recommended for all patients who develop superior vena cava syndrome. | Elective [[stent]] placement and [[Bypass|surgical bypass]] is recommended for all [[patients]] who develop [[superior vena cava syndrome]]. | ||
==Surgery== | ==Surgery== | ||
===Stent Placement=== | ===Stent Placement=== | ||
There have been numerous small studies that used an intravascular expandable stent to reopen the occluded [[SVC]]; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for [[anticoagulant]] therapy after stent placement. In one series that used anticoagulant therapy for patients as part of the treatment protocol, there were reports of re-occlusion after this therapy was stopped. However, in another study, 17 [[cancer]] patients who were treated with stents and who did not have anticoagulant therapy had no occlusions. | There have been numerous small studies that used an intravascular expandable [[stent]] to reopen the occluded [[SVC]]; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for [[anticoagulant]] therapy after [[stent]] placement. In one series that used [[anticoagulant therapy]] for [[patients]] as part of the treatment protocol, there were reports of re-occlusion after this [[therapy]] was stopped. However, in another study, 17 [[cancer]] patients who were treated with [[stents]] and who did not have [[anticoagulant therapy]] had no occlusions. | ||
===Surgical Bypass=== | ===Surgical Bypass=== | ||
Surgical bypass is more appropriate for patients with a [[benign]] obstruction than with a [[malignant]] obstruction, although surgical bypass has also been used for patients with malignant obstructions. | [[Bypass|Surgical bypass]] is more appropriate for [[patients]] with a [[benign]] [[obstruction]] than with a [[malignant]] obstruction, although [[Bypass|surgical bypass]] has also been used for [[patients]] with [[Malignant|malignant obstructions]]. | ||
==References== | ==References== | ||
Latest revision as of 14:35, 12 April 2019
|
Superior Vena Cava Syndrome Microchapters |
|
Differentiating Superior Vena Cava Syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Superior vena cava syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Superior vena cava syndrome surgery |
|
Directions to Hospitals Treating Superior vena cava syndrome |
|
Risk calculators and risk factors for Superior vena cava syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Elective stent placement and surgical bypass is recommended for all patients who develop superior vena cava syndrome.
Surgery
Stent Placement
There have been numerous small studies that used an intravascular expandable stent to reopen the occluded SVC; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for anticoagulant therapy after stent placement. In one series that used anticoagulant therapy for patients as part of the treatment protocol, there were reports of re-occlusion after this therapy was stopped. However, in another study, 17 cancer patients who were treated with stents and who did not have anticoagulant therapy had no occlusions.
Surgical Bypass
Surgical bypass is more appropriate for patients with a benign obstruction than with a malignant obstruction, although surgical bypass has also been used for patients with malignant obstructions.